ArticleScience translational medicine2014

Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

Sam C Nalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.